-Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103, A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer

Press/Media

Period2 Apr 2024

Media coverage

2

Media coverage

  • Title-Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103, A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
    Media name/outletM2 PressWIRE
    Country/TerritoryUnited States
    Date2/04/24
    PersonsMatthew Galsky
  • Title-Natera and Alliance for Clinical Trials in Oncology Announce Activation of Alliance A032103, A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date2/04/24
    PersonsMatthew Galsky